Overall, the results from the in vitro and in vivo models indicated that tumor‐secreted galectin‐9 mediated immune suppressive effects on T cells by suppressing T‐cell proliferation, inhibiting the cytotoxicity of CD8+ T cells, promoting the apoptosis and exhaustion of CD8+ T cells and inducing the Treg fraction. This evidence concerns the gene CD8A and neoplasm.